-
1.
公开(公告)号:EP2483274B1
公开(公告)日:2014-10-29
申请号:EP10821105.3
申请日:2010-09-28
申请人: Board of Regents, The University of Texas System , Monash University , MMV Medicines for Malaria Venture , University of Washington , Glaxosmithkline Investigacion y Desarrollo, S.L.
发明人: RATHOD, Pradipsinh, K. , FLOYD, David , BURROWS, Jeremy , MARWAHA, Alka , GUJJAR, Ramesh , COTERON-LOPEZ, Jose , PHILLIPS, Margaret , CHARMAN, Susan, A. , MATTHEWS, David
IPC分类号: C07D487/04 , A61K31/519 , A61P33/06
CPC分类号: C07D487/04
-
2.
公开(公告)号:EP2483274A2
公开(公告)日:2012-08-08
申请号:EP10821105.3
申请日:2010-09-28
申请人: Board of Regents, The University of Texas System , Monash University , Medicines For Malaria Venture , University of Washington , Glaxosmithkline Investigacion y Desarrollo, S.L.
发明人: RATHOD, Pradipsinh, K. , FLOYD, David , BURROWS, Jeremy , MARWAHA, Alka , GUJJAR, Ramesh , COTERON-LOPEZ, Jose , PHILLIPS, Margaret , CHARMAN, Susan, A. , MATTHEWS, David
IPC分类号: C07D487/04 , A61K31/519 , A61P33/06
CPC分类号: C07D487/04
摘要: Inhibitors of parasitic dihydroorotate dehydrogenase enzyme (DHOD) are candidate therapeutics for treating malaria. Illustrative of such therapeutic agents include the compound: and a triazolopyrimidine class of compounds that conform to Formula (IX): and their solvates, stereoisomers, tautomers and pharmaceutically acceptable salts.
-